WuXi Biologics (Cayman) Inc. (WXXWY)
USD 4.3
(-1.15%)
USD 4.3
(-1.15%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.87 Billion CNY | 67.72% |
| 2022 | 1.41 Billion CNY | 65.88% |
| 2021 | 854.61 Million CNY | 41.18% |
| 2020 | 605.33 Million CNY | 2.91% |
| 2019 | 588.21 Million CNY | 59.49% |
| 2018 | 368.8 Million CNY | 11.78% |
| 2017 | 329.92 Million CNY | 103.81% |
| 2016 | 161.88 Million CNY | 33.96% |
| 2015 | 120.84 Million CNY | 67.06% |
| 2014 | 72.33 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.53 Billion CNY | 0.0% |
| 2023 Q4 | 1.62 Billion CNY | 0.0% |
| 2023 FY | 2.37 Billion CNY | 67.72% |
| 2023 Q2 | 1.02 Billion CNY | 0.0% |
| 2022 FY | 1.41 Billion CNY | 65.88% |
| 2022 Q2 | 512.72 Million CNY | 0.0% |
| 2022 Q4 | 904.92 Million CNY | 0.0% |
| 2021 Q4 | 610.59 Million CNY | 0.0% |
| 2021 Q2 | 244.01 Million CNY | 0.0% |
| 2021 FY | 854.61 Million CNY | 41.18% |
| 2020 Q2 | 84.21 Million CNY | 0.0% |
| 2020 FY | 605.33 Million CNY | 2.91% |
| 2020 Q4 | 521.11 Million CNY | 0.0% |
| 2019 FY | 588.21 Million CNY | 59.49% |
| 2019 Q4 | 397.93 Million CNY | 0.0% |
| 2019 Q2 | 190.28 Million CNY | 0.0% |
| 2018 FY | 368.8 Million CNY | 11.78% |
| 2018 Q4 | 212.89 Million CNY | 0.0% |
| 2018 Q2 | 155.9 Million CNY | 0.0% |
| 2017 FY | 329.92 Million CNY | 103.81% |
| 2017 Q2 | 117.54 Million CNY | 0.0% |
| 2017 Q4 | 212.37 Million CNY | 0.0% |
| 2016 Q2 | 80.89 Million CNY | 0.0% |
| 2016 Q4 | 108.62 Million CNY | 0.0% |
| 2016 FY | 161.88 Million CNY | 33.96% |
| 2015 Q4 | 34.63 Million CNY | 0.0% |
| 2015 FY | 120.84 Million CNY | 67.06% |
| 2015 Q1 | 34.63 Million CNY | 59.62% |
| 2015 Q2 | 34.63 Million CNY | 0.0% |
| 2015 Q3 | 34.63 Million CNY | 0.0% |
| 2014 Q3 | 21.69 Million CNY | 0.0% |
| 2014 Q1 | 21.69 Million CNY | 0.0% |
| 2014 FY | 72.33 Million CNY | 0.0% |
| 2014 Q4 | 21.69 Million CNY | 0.0% |
| 2014 Q2 | 21.69 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | -3216.746% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -58429.665% |
| SQZ Biotechnologies Company | 85.61 Million USD | -3261.915% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -9639.918% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | -7626.174% |
| Mesoblast Limited | 5.9 Million USD | -48670.552% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -191553.234% |
| Genus plc | 147.7 Million USD | -1848.841% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -32686.892% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -214461.42% |
| Marizyme, Inc. | 19.23 Million USD | -14860.827% |
| ContraFect Corporation | 56.88 Million USD | -4959.744% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -34417.784% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -65190.364% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -194553.194% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -98603.911% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -103056.621% |
| MultiCell Technologies, Inc. | 567.42 USD | -507285155.895% |
| Accustem Sciences Inc. | 3.74 Million USD | -76731.716% |
| RVL Pharmaceuticals plc | 85.94 Million USD | -3249.163% |
| EV Biologics, Inc. | 531.96 Thousand USD | -540998.424% |
| Q BioMed Inc. | 3.43 Million USD | -83657.625% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -11546.522% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -738783.27% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -109449.53% |
| Biomind Labs Inc. | 994.18 Thousand USD | -289428.275% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 225.49 Million USD | -1176.52% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -42746.555% |
| Skye Bioscience, Inc. | 13.54 Million USD | -21146.927% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -140400.365% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 11513851.996% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -56988.712% |
| IMV Inc. | 37.7 Million USD | -7533.248% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -17878.734% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -156754.986% |
| GB Sciences, Inc. | 1.42 Million USD | -202534.267% |
| Alpha Cognition Inc. | 9.7 Million USD | -29557.494% |
| HST Global, Inc. | 140.9 Thousand USD | -2042692.763% |
| CSL Limited | 3.44 Billion USD | 16.543% |
| Halberd Corporation | 74.84 Thousand USD | -3845919.613% |
| Enzolytics Inc. | 2.17 Million USD | -131968.307% |
| Resverlogix Corp. | 12.71 Million USD | -22543.471% |
| Affymax, Inc. | 39.38 Million USD | -7208.277% |
| SYBLEU INC | 160.87 Thousand USD | -1789127.728% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -78746.043% |
| argenx SE | 1.53 Billion USD | -87.7% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | -4911.208% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -275612.452% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -182154.021% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -84436.145% |
| AVAX Technologies, Inc. | 7.31 Million USD | -39275.295% |
| Zenith Capital Corp. | 8.94 Million USD | -32086.492% |
| Genscript Biotech Corporation | 825.34 Million USD | -248.756% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -16522705.803% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -117132.846% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -1678201.43% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | -2797.849% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -163477.541% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 1.97 Million USD | -145862.899% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -154291.993% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -26387.881% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -149747.936% |
| BioStem Technologies, Inc. | 22.97 Million USD | -12428.674% |
| ONE Bio Corp. | 6.44 Million USD | -44569.246% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -1585947.331% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -215443.746% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -255781.626% |
| Agentix Corp. | 1.37 Million USD | -209736.006% |
| LadRx Corporation | 3.81 Million USD | -75414.056% |
| Cell Source, Inc. | 4.32 Million USD | -66448.156% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -692699.877% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -311584.551% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -311584.551% |
| NovAccess Global Inc. | 2.46 Million USD | -116588.97% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -119588.856% |
| Itoco Inc. | 919.14 Thousand USD | -313065.416% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -67813.092% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -257133.065% |
| Kadimastem Ltd | 2.41 Million USD | -119331.711% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -1099690.62% |
| CytoDyn Inc. | 18.05 Million USD | -15839.96% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -11436341.65% |
| Mobile Lads Corp. | 554.54 Thousand USD | -518962.079% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -1307817.193% |
| Qrons Inc. | 643.67 Thousand USD | -447086.71% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -202636.598% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | -128984.941% |
| Rebus Holdings, Inc. | 664 Thousand USD | -433399.699% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -158376.37% |
| International Stem Cell Corporation | 5.27 Million USD | -54508.955% |
| Bioxytran, Inc. | 3.82 Million USD | -75248.881% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -5467849.544% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -14149425.63% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -7837.015% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -177800.989% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -391079.816% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -92424.526% |
| Neutra Corp. | 243.82 Thousand USD | -1180453.766% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -16388.732% |
| PureTech Health plc | 144.59 Million USD | -1890.662% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -13948.09% |
| IXICO plc | 4.7 Million USD | -61052.284% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -32620.677% |
| Gelesis Holdings, Inc. | 117.74 Million USD | -2344.575% |
| CSL Limited | 3.89 Billion USD | 26.061% |
| Cellectis S.A. | 97.32 Million USD | -2857.704% |